MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983–1997
Marcel A. Müller
1
, Victor Max Corman
1, Joerg Jores, Benjamin Meyer, Mario Younan, Anne M. Liljander, Berend-Jan Bosch, Erik Lattwein, Mosaad Hilali, Bakri E. Musa, Set Bornstein, and Sung Sup Park
Author affiliations: University of Bonn Medical Centre, Bonn, Germany (M.A. Müller, V.M. Corman, B. Meyer, C. Drosten); German Centre for Infection Research, Bonn (V.M. Corman); International Livestock Research Institute, Nairobi, Kenya (J. Jores, A. Liljander); Vétérinaires Sans Frontières Germany, Nairobi (M. Younan); Utrecht University, Utrecht, the Netherlands (B.-J. Bosch); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Cairo University, Giza, Egypt (M. Hilali); Ministry of Science and Communication, Khartoum, Sudan (B.E. Musa); National Veterinary Institute, Uppsala, Sweden (S. Bornstein)
Main Article
Table 2
MERS-CoV neutralizing antibody titers in dromedary camels from eastern Africa*
Country, date |
No. samples |
mNT titer, no. (%) samples†
|
<80 |
80–800 |
>800 |
Egypt, 1997 Jul |
43 |
9 (20.9) |
29 (67.4) |
5 (11.6) |
Somalia |
|
|
|
|
1983 Jan–Nov |
25 |
8 (32.0) |
14 (56.0) |
3 (12.0) |
1984 Feb–Dec |
61 |
8 (13.1) |
45 (73.8) |
8 (13.1) |
Sudan, 1983 Jun |
60 |
11 (18.3) |
36 (60.0) |
13 (21.7) |
Total |
189 |
36 (19.0) |
124 (65.6) |
29 (15.3) |
Main Article
Page created: November 19, 2014
Page updated: November 19, 2014
Page reviewed: November 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.